Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
19.37
-0.34 (-1.73%)
Mar 9, 2026, 3:00 PM CST
SHA:600079 Revenue
Humanwell Healthcare (Group) had revenue of 5.82B CNY in the quarter ending September 30, 2025, a decrease of -7.36%. This brings the company's revenue in the last twelve months to 24.18B, down -5.40% year-over-year. In the year 2024, Humanwell Healthcare (Group) had annual revenue of 25.44B with 3.71% growth.
Revenue (ttm)
24.18B
Revenue Growth
-5.40%
P/S Ratio
1.31
Revenue / Employee
1.37M
Employees
17,650
Market Cap
31.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.44B | 910.74M | 3.71% |
| Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
| Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
| Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
| Dec 31, 2020 | 20.68B | -1.13B | -5.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dong-E-E-Jiao | 6.12B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 5.37B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Livzon Pharmaceutical Group | 11.85B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Kangmei Pharmaceutical | 5.28B |
| Chengdu Kanghong Pharmaceutical Group | 4.67B |
| Hubei Jumpcan Pharmaceutical | 6.14B |